Lyra Therapeutics (LYRA) Competitor Comparison
We are evaluating the key criteria listed to compare Lyra Therapeutics (LYRA) against its competitors in the Biotechnology industry.
Market Capitalization
206 / 368Gross Profits
183 / 278Total Revenue
229 / 300EBITDA
154 / 337Free Cashflow
161 / 352Quick Ratio
177 / 357Earnings per Share
134 / 359Dividend yield
0 / 5Total Cash
213 / 358Performance 3 years
199 / 368Performance 5 years
265 / 368Performance 10 years
234 / 368Linearity 3 years
131 / 368Linearity 5 years
194 / 368Linearity 10 years
216 / 368Total Rank
187 / 368Dividend Rank
193 / 368Valuation Rank
216 / 368Piotroski Rank
83 / 368Muliplier Rank
146 / 368Dividend Rank - LYRA ranking 193 / 368
Obligatory risk notice
We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.